Integra LifeSciences Holdings Corp. will purchase Johnson & Johnson's Codman neurosurgery business for $1.05 billion, reports Reuters.
Here are four things to know.
1. Integra develops products for neurosurgery, reconstruction, wound and dental care.
2. Codman neurosurgery business — part of J&J's DePuy Synthes unit — offers a portfolio of tissue ablation, spinal cord repair and cranial stabilization products.
3. Integra made a "binding offer" for the Codman business, although the deal is still pending approval from various works councils and regulators, a J&J spokeswoman told Reuters.
4. If approved by various works councils and regulators, the deal will close in the fourth quarter of 2017.
More articles on supply chain:
Skin cream costs vary based on prescribing provider, study finds
Hologic to acquire Cynosure for $1.6B: 3 things to know
Former FDA commissioner shares 4 thoughts on streamlining drug approvals